- Home
- CEPS vs MBOT Comparison
CEPS vs MBOT Comparison
Compare CEPS & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CEPS | MBOT |
|---|---|---|
| Founded | 2021 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.9M | 166.6M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | CEPS | MBOT |
|---|---|---|
| Price | $10.09 | $2.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 16.3K | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.07 | $1.60 |
| 52 Week High | $10.18 | $4.62 |
Technical Indicators
Market Signals| Indicator | CEPS | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 42.52 | 49.48 |
| Support Level | N/A | $2.34 |
| Resistance Level | $10.13 | $2.67 |
| Average True Range (ATR) | 0.02 | 0.15 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 33.33 | 35.85 |
Price Performance
Historical ComparisonAbout CEPS Cantor Equity Partners VI Inc. Class A Ordinary Shares
Cantor Equity Partners VI Inc is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.